{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:20:50Z","timestamp":1764174050083,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.joca.2014.01.005","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T02:15:27Z","timestamp":1391220927000},"page":"415-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?"],"prefix":"10.1016","volume":"22","author":[{"given":"E.","family":"Losina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Burbine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.G.","family":"Suter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Daigle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.E.","family":"Dervan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2014.01.005_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.01.005_bib2","first-page":"1177","article-title":"Cost-effectiveness of ACR guideline-based care and lifetime direct medical costs attributable to knee OA management in the US","volume":"60 (S10)","author":"Losina","year":"2009"},{"key":"10.1016\/j.joca.2014.01.005_bib3","first-page":"S230","article-title":"The economic burden of osteoarthritis","volume":"15","author":"Bitton","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.joca.2014.01.005_bib4","first-page":"646","article-title":"Burden of major musculoskeletal conditions","volume":"81","author":"Woolf","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.joca.2014.01.005_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis","volume":"26","author":"Zhang","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.joca.2014.01.005_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.joca.2009.08.010","article-title":"Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis","volume":"18","author":"Blagojevic","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.01.005_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/bjsm.2010.081117","article-title":"Lower extremity osteoarthritis management needs a paradigm shift","volume":"45","author":"Hunter","year":"2011","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.joca.2014.01.005_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mcna.2008.07.011","article-title":"How close are we to having structure-modifying drugs available?","volume":"93","author":"Hunter","year":"2009","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.joca.2014.01.005_bib9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.joca.2013.01.016","article-title":"Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?","volume":"21","author":"Losina","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.01.005_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.24337","article-title":"Is obesity a risk factor for progressive radiographic knee osteoarthritis?","volume":"61","author":"Niu","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.01.005_bib11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1","article-title":"Risk factors for the incidence and progression of radiographic knee osteoarthritis","volume":"43","author":"Cooper","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.01.005_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/joca.2002.0795","article-title":"History of acute knee injury and osteoarthritis of the knee: a prospective epidemiological assessment. The Clearwater Osteoarthritis Study","volume":"10","author":"Wilder","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.01.005_bib13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the panel on cost-effectiveness in health and medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.joca.2014.01.005_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.joca.2010.10.009","article-title":"Forecasting the burden of advanced knee osteoarthritis over a 10-year period in a cohort of 60\u201364 year-old US adults","volume":"19","author":"Holt","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.01.005_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7326\/0003-4819-154-4-201102150-00001","article-title":"Impact of obesity and knee osteoarthritis on Morbidity and mortality in older Americans","volume":"154","author":"Losina","year":"2011","journal-title":"Ann Intern Med"},{"year":"2007","series-title":"National Center for Health Statistics","author":"Centers for Disease Control and Prevention","key":"10.1016\/j.joca.2014.01.005_bib16"},{"year":"2006","series-title":"2005\u20132006 National Health and Nutrition Examination Survey (NHANES) Data","author":"Centers for Disease Control and Prevention (CDC)","key":"10.1016\/j.joca.2014.01.005_bib17"},{"year":"2008","series-title":"2007\u20132008 National Health and Nutrition Examination Survey (NHANES) Data","author":"Centers for Disease Control and Prevention (CDC)","key":"10.1016\/j.joca.2014.01.005_bib18"},{"key":"10.1016\/j.joca.2014.01.005_bib19","article-title":"United States life tables, 2006","volume":"vol. 58","author":"Arias","year":"2010"},{"key":"10.1016\/j.joca.2014.01.005_bib20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0895-4356(98)00103-6","article-title":"Deriving a preference-based single index from the UK SF-36 Health Survey","volume":"51","author":"Brazier","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.joca.2014.01.005_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/00005650-200107000-00004","article-title":"Transforming self-rated health and the SF-36 scales to include\u00a0death and improve interpretability","volume":"39","author":"Diehr","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.joca.2014.01.005_bib22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archinternmed.2009.136","article-title":"Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume","volume":"169","author":"Losina","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.joca.2014.01.005_bib23","doi-asserted-by":"crossref","first-page":"e62709","DOI":"10.1371\/journal.pone.0062709","article-title":"Placing a price on medical device innovation: the example of total knee arthroplasty","volume":"8","author":"Suter","year":"2013","journal-title":"PLoS One"},{"year":"2010","series-title":"Annual Estimates of the Hispanic, White, and Black Resident Populations by Sex and Age for the United States: April 1, 2000 to July 1, 2009 (NC-EST2009-04-HISP\/WANH\/BA)","key":"10.1016\/j.joca.2014.01.005_bib24"},{"key":"10.1016\/j.joca.2014.01.005_bib25","first-page":"119","article-title":"Risk adjustment of Medicare capitation payments using the CMS-HCC model","volume":"25","author":"Pope","year":"2004","journal-title":"Health Care Financ Rev"},{"year":"2010","series-title":"Red Book: Pharmacy's Fundamental Reference: 2010 Edition","key":"10.1016\/j.joca.2014.01.005_bib26"},{"year":"2006","series-title":"Medicare Current Beneficiary Survey","key":"10.1016\/j.joca.2014.01.005_bib27"},{"key":"10.1016\/j.joca.2014.01.005_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/acr.21898","article-title":"Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US","volume":"65","author":"Losina","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"year":"2004","series-title":"2003\u20132004 National Health and Nutrition Examination Survey (NHANES) Data","author":"Centers for Disease Control and Prevention (CDC)","key":"10.1016\/j.joca.2014.01.005_bib29"},{"key":"10.1016\/j.joca.2014.01.005_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/berh.2001.0177","article-title":"Injections in the treatment of osteoarthritis","volume":"15","author":"Ayral","year":"2001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.joca.2014.01.005_bib31","series-title":"Osteoarthritis","article-title":"Intra-articular therapies in osteoarthritis","author":"Jones","year":"1998"},{"key":"10.1016\/j.joca.2014.01.005_bib32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/rheumatology\/38.12.1272","article-title":"Frequency of sepsis after local corticosteroid injection (an inquiry on 1160000 injections in rheumatological private practice in France)","volume":"38","author":"Seror","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2014.01.005_bib33","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1996.03540160061034","article-title":"Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine","volume":"276","author":"Siegel","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.joca.2014.01.005_bib34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.joca.2014.01.005_bib35","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update","volume":"43","author":"American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.01.005_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2014.01.005_bib37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2106\/JBJS.I.00982","article-title":"American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee","volume":"92","author":"Richmond","year":"2010","journal-title":"J\u00a0Bone Joint Surg Am"},{"year":"2008","series-title":"Treatment of Osteoarthritis of the Knee (Non-arthroplasty): Full Guideline","key":"10.1016\/j.joca.2014.01.005_bib38"},{"key":"10.1016\/j.joca.2014.01.005_bib39","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"year":"2010","series-title":"Medicare Fee Schedules","key":"10.1016\/j.joca.2014.01.005_bib40"},{"year":"2011","series-title":"Medicare Hospital Inpatient Prospective Payment System","key":"10.1016\/j.joca.2014.01.005_bib41"},{"year":"2009","series-title":"Nationwide Inpatient Sample (NIS)","author":"Healthcare Cost and Utilization Project (HCUP)","key":"10.1016\/j.joca.2014.01.005_bib42"},{"key":"10.1016\/j.joca.2014.01.005_bib43","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/rheumatology\/39.10.1095","article-title":"The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial","volume":"39","author":"Scott","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.joca.2014.01.005_bib44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.22333","article-title":"Association of hospital and surgeon procedure volume with patient-centered outcomes of total knee replacement in a population-based cohort of patients age 65 years and older","volume":"56","author":"Katz","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.joca.2014.01.005_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2106\/JBJS.J.00807","article-title":"A\u00a0prospective study of 80,000 total joint and 5000 anterior cruciate ligament reconstruction procedures in a community-based registry in the United States","volume":"92","author":"Paxton","year":"2010","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.joca.2014.01.005_bib46","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4065\/74.11.1095","article-title":"Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial","volume":"74","author":"Bensen","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.joca.2014.01.005_bib47","first-page":"25","article-title":"Significant upper gastrointestinal events associated with conventional NSAID versus celecoxib","volume":"60","author":"Goldstein","year":"2000","journal-title":"J\u00a0Rheumatol Suppl"},{"key":"10.1016\/j.joca.2014.01.005_bib48","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.joca.2014.01.005_bib49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jval.2012.04.014","article-title":"Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20136","volume":"15","author":"Briggs","year":"2012","journal-title":"Value Health"},{"year":"2008","series-title":"Nationwide Inpatient Sample (NIS)","author":"Healthcare Cost and Utilization Project (HCUP)","key":"10.1016\/j.joca.2014.01.005_bib50"},{"key":"10.1016\/j.joca.2014.01.005_bib51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1524-4733.2003.00215.x","article-title":"The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis","volume":"6","author":"Kamath","year":"2003","journal-title":"Value Health"},{"year":"2011","series-title":"Using Ace Inhibitors to Treat High Blood Pressure and Heart Disease: Comparing Effectiveness, Safety, and Price","key":"10.1016\/j.joca.2014.01.005_bib52"},{"year":"2011","series-title":"Using Beta-blockers to Treat High Blood Pressure and Heart Disease: Comparing Effectiveness, Safety, and Price","key":"10.1016\/j.joca.2014.01.005_bib53"},{"year":"2010","series-title":"Evaluating Statin Drugs to Treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price","key":"10.1016\/j.joca.2014.01.005_bib54"},{"year":"2010","series-title":"Medicare Hospital Outpatient Prospective Payment System","key":"10.1016\/j.joca.2014.01.005_bib55"},{"key":"10.1016\/j.joca.2014.01.005_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MLR.0b013e31815c31a7","article-title":"What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?","volume":"46","author":"Braithwaite","year":"2008","journal-title":"Med Care"},{"key":"10.1016\/j.joca.2014.01.005_bib57","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.163.14.1637","article-title":"What is the price of life and why doesn't it increase at the rate of inflation?","volume":"163","author":"Ubel","year":"2003","journal-title":"Arch Intern Med"},{"year":"2003","series-title":"Hidden Costs, Value Lost: Uninsurance in America","key":"10.1016\/j.joca.2014.01.005_bib58"},{"key":"10.1016\/j.joca.2014.01.005_bib59","first-page":"S389","article-title":"The cost effectiveness of tamoxifen in the prevention of breast cancer","volume":"5","author":"Noe","year":"1999","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.joca.2014.01.005_bib60","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-135-10-200111200-00007","article-title":"Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction","volume":"135","author":"Sanders","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joca.2014.01.005_bib61","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00167-008-0498-x","article-title":"Function, osteoarthritis and activity after ACL-rupture: 11 years follow-up results of conservative versus reconstructive treatment","volume":"16","author":"Kessler","year":"2008","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.joca.2014.01.005_bib62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.knee.2008.11.004","article-title":"Osteoarthritis in patients with anterior cruciate\u00a0ligament rupture: a review of risk factors","volume":"16","author":"Louboutin","year":"2009","journal-title":"Knee"},{"key":"10.1016\/j.joca.2014.01.005_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JES.0b013e3181aa6669","article-title":"A\u00a0neuromuscular mechanism of posttraumatic osteoarthritis associated with ACL injury","volume":"37","author":"Palmieri-Smith","year":"2009","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1016\/j.joca.2014.01.005_bib64","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.rdc.2008.04.007","article-title":"Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management","volume":"34","author":"Messier","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.joca.2014.01.005_bib65","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.2013.277669","article-title":"Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial","volume":"310","author":"Messier","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.joca.2014.01.005_bib66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-116-7-535","article-title":"Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study","volume":"116","author":"Felson","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joca.2014.01.005_bib67","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9","article-title":"An update on the epidemiology of knee and hip osteoarthritis with a view to prevention","volume":"41","author":"Felson","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.01.005_bib68","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/art.20256","article-title":"Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the arthritis, diet, and activity promotion trial","volume":"50","author":"Messier","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.01.005_bib69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/acr.20464","article-title":"What if we prevent obesity? Risk reduction in knee osteoarthritis estimated through a meta-analysis of observational studies","volume":"63","author":"Muthuri","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.joca.2014.01.005_bib70","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.22245","article-title":"Effects of strength training on the incidence and progression of knee osteoarthritis","volume":"55","author":"Mikesky","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2014.01.005_bib71","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2012-202159","article-title":"Associations between statin use and changes in pain, function and structural progression: a longitudinal study of persons with knee osteoarthritis","volume":"72","author":"Riddle","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.01.005_bib72","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/annrheumdis-2013-203546","article-title":"Response to comments in: statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study by Clockaerts et\u00a0al","volume":"72","author":"Riddle","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.01.005_bib73","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/annrheumdis-2011-200092","article-title":"Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study","volume":"71","author":"Clockaerts","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.01.005_bib74","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/annrheumdis-2011-201135","article-title":"The effects of statins on osteoarthritis structural progression: another glimpse of the Holy Grail?","volume":"71","author":"Conaghan","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2014.01.005_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jbspin.2010.02.035","article-title":"Statins: a potential role in the management of osteoarthritis?","volume":"78","author":"Baker","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.joca.2014.01.005_bib76","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11606-013-2382-8","article-title":"Statin use and clinical osteoarthritis in the general population: a longitudinal study","volume":"28","author":"Kadam","year":"2013","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.joca.2014.01.005_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13547500903295873","article-title":"Application of biochemical markers in development of drugs for treatment of osteoarthritis","volume":"15","author":"Qvist","year":"2010","journal-title":"Biomarkers"},{"key":"10.1016\/j.joca.2014.01.005_bib78","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJM200206063462309","article-title":"Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease","volume":"346","author":"Gaspoz","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.joca.2014.01.005_bib79","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCOUTCOMES.108.808469","article-title":"Statin cost-effectiveness in the United States for people at different vascular risk levels","volume":"2","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.joca.2014.01.005_bib80","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jama.1995.03530230025025","article-title":"Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation","volume":"274","author":"Gage","year":"1995","journal-title":"JAMA"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458414000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458414000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:32:04Z","timestamp":1761017524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458414000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1063458414000181"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2014.01.005","relation":{},"ISSN":["1063-4584"],"issn-type":[{"type":"print","value":"1063-4584"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2014.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}